445 related articles for article (PubMed ID: 17404475)
21. Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
Quinn M
J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971
[No Abstract] [Full Text] [Related]
22. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
23. Problems and paradigms in joint pathology.
Gardner DL
J Anat; 1994 Jun; 184 ( Pt 3)(Pt 3):465-76. PubMed ID: 7928636
[TBL] [Abstract][Full Text] [Related]
24. [Mechanisms of articular destruction in rheumatoid arthritis].
Dayer JM
Rev Med Brux; 1985 Apr; 6(4):311-3. PubMed ID: 4001666
[No Abstract] [Full Text] [Related]
25. Uncoupling of inflammation and destruction in rheumatoid arthritis: myth or reality?
van den Berg WB; van Riel PL
Arthritis Rheum; 2005 Apr; 52(4):995-9. PubMed ID: 15818666
[No Abstract] [Full Text] [Related]
26. [Role of osteoclasts in bone destruction in rheumatoid arthritis].
Suzuki Y
Nihon Rinsho Meneki Gakkai Kaishi; 2001 Jun; 24(3):87-97. PubMed ID: 16578961
[No Abstract] [Full Text] [Related]
27. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
[TBL] [Abstract][Full Text] [Related]
28. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
29. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction.
Mor A; Abramson SB; Pillinger MH
Clin Immunol; 2005 May; 115(2):118-28. PubMed ID: 15885632
[TBL] [Abstract][Full Text] [Related]
30. [Destruction and inflammation of the joints in rheumatoid arthritis: a pathogenic hypothesis (author's transl)].
Dayer JM; Héron JF
Nouv Presse Med; 1981 Mar; 10(13):1065-8. PubMed ID: 6261219
[TBL] [Abstract][Full Text] [Related]
31. [Cartilage degradation in rheumatoid arthritis].
Ishiguro N
Clin Calcium; 2009 Mar; 19(3):347-54. PubMed ID: 19252244
[TBL] [Abstract][Full Text] [Related]
32. Molecular biology of cartilage and bone destruction.
Müller-Ladner U; Gay RE; Gay S
Curr Opin Rheumatol; 1998 May; 10(3):212-9. PubMed ID: 9608324
[TBL] [Abstract][Full Text] [Related]
33. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
34. [Destruction of articular cartilage].
Koike T
Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
[TBL] [Abstract][Full Text] [Related]
35. Comparative histopathological analysis between tenosynovitis and joint synovitis in rheumatoid arthritis.
Kaibara N; Yamada H; Shuto T; Nakashima Y; Okazaki K; Miyahara H; Esaki Y; Hirata G; Iwamoto Y
Histopathology; 2008 Jun; 52(7):856-64. PubMed ID: 18462359
[TBL] [Abstract][Full Text] [Related]
36. [Clinical value of histomorphologic studies of joint capsules].
Laschner W; Fritz P; Mischlinski A; Mischlinski G; Rautenstrauch H; Saal HJ; Tuczek HV; Wegner G
Z Rheumatol; 1988; 47(4):195-200. PubMed ID: 3188676
[TBL] [Abstract][Full Text] [Related]
37. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities.
Brentano F; Schorr O; Ospelt C; Stanczyk J; Gay RE; Gay S; Kyburz D
Arthritis Rheum; 2007 Sep; 56(9):2829-39. PubMed ID: 17763446
[TBL] [Abstract][Full Text] [Related]
38. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson SB; Amin A
Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
[TBL] [Abstract][Full Text] [Related]
39. Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts.
Huber LC; Künzler P; Boyce SH; Michel BA; Gay RE; Ink BS; Gay S
Ann Rheum Dis; 2008 Mar; 67(3):389-94. PubMed ID: 17660218
[TBL] [Abstract][Full Text] [Related]
40. What destroys the joint in rheumatoid arthritis?
Fassbender HG
Arch Orthop Trauma Surg; 1998; 117(1-2):2-7. PubMed ID: 9457327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
